Category Archives: Disease

Lilly Alzheimer’s drug, like so many others, fails; will true breakthrough happen this century?

Eli Lilly & Co. (Indianapolis RIN) said its experimental Alzheimer’s treatment failed to slow loss of cognitive ability in patients with mild symptoms, a major setback for the company and millions of… Read more »

New Zika treatment that protects pregnant mice could help protect pregnant women, fetuses; who owns development rights?

In early studies on mice, a research team has found a Zika virus antibody that when given to pregnant animals protected their fetuses, and also protected adult mice from the… Read more »

Cempra stock tanks on FDA concerns for lead drug’s side-effects; high hopes still riding on Friday AdCom meeting

Cempra Inc.’s (Chapel Hill NC) experimental drug to treat community-acquired pneumonia, the kind recently suffered by presidential candidate Hillary Clinton, causes a potentially concerning rise in liver enzymes, according to… Read more »

Johnson & Johnson Tumbles as Pfizer Set to Launch Remicade Biosimilar; Solid 3rd Quarter Doesn’t Quell Market’s Overreaction

Thriving pharmaceutical sales drove stellar quarterly results for Johnson & Johnson (New Brunswick NJ), but the company’s shares fell 3% so far this week on worries that its smash hit,… Read more »

Zika Funding Plan Announced By Obama Officials; But Why the Long Delay After Congress Finally Voted Them?

US health officials outlined on Tuesday (October 18, 2016) how they planned to divide up $1.1 billion in funds approved by Congress to fight the Zika virus, including repaying $44.25… Read more »

Bristol Myers Clobbered as Cancer Drug Disappoints; Rival Merck Unanimous Winner at Medical Conference

New data are likely to prompt doctors to abandon Bristol-Myers Squibb Co.’s (New York City) immunotherapy Opdivo in favor of Merck & Co.’s (Kenilworth NJ) rival Keytruda in a large… Read more »

Theranos Pivots From Blood Tests to New Lab Product; Will “Phoenix” Effort Succeed?

Beleaguered startup Theranos Inc. (Palo Alto CA) will close its blood-testing labs and fire about 340 workers, shifting its focus to an experimental technology following months of run-ins with regulators and… Read more »

Danger of Superbugs Finally Gets Attention, But Not Much Action

Common infections such as pneumonia, gonorrhea, and post-operative infections, as well as HIV, tuberculosis and malaria, are becoming increasingly hard to treat because of antimicrobial resistance. And there is now… Read more »

Congress Finally Ends Row Over Zika Funding; Months of Lost Vaccine Progress a Shameful Legacy

More than eight months after the White House first asked for it, Congress has finally agreed on some funding to help fight the Zika virus and study its effects. President… Read more »

It’s the 11th Hour and Congress Still Bargaining Over Zika Funding; Nation’s Health Lies In The Balance

Congressional negotiators on Monday pressed to wrap up a must-do spending bill to prevent an election-season government shutdown and finally provide money to battle the threat of the Zika virus,… Read more »